Journal article
Cetuximab in Metastatic Squamous Cell Cancer of the Skin: A Swiss Case Series
Abstract
BACKGROUND: There is current evidence that non-melanoma skin cancers can be successfully treated with cetuximab.
OBJECTIVE: To evaluate the use and efficacy of cetuximab (with or without radiotherapy) in a series of previously treated patients with metastatic squamous cell cancer of the skin (SCCS) in Switzerland.
Authors
Conen KL; Fischer N; Hofbauer GFL; Shafaeddin-Schreve B; Winterhalder R; Rochlitz C; Zippelius A
Journal
Dermatology, Vol. 229, No. 2, pp. 97–101
Publisher
Karger Publishers
Publication Date
2014
DOI
10.1159/000362384
ISSN
1018-8665
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAntibodies, Monoclonal, HumanizedAntineoplastic AgentsCarcinoma, Squamous CellCetuximabDisease-Free SurvivalDose-Response Relationship, DrugErbB ReceptorsFemaleFollow-Up StudiesHumansMaleNeoplasm MetastasisPrognosisRetrospective StudiesSkin NeoplasmsSurvival RateSwitzerlandTime FactorsTreatment Outcome